| Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand? S Baig, I Seevasant, J Mohamad, A Mukheem, HZ Huri, T Kamarul Cell death & disease 7 (1), e2058-e2058, 2016 | 320 | 2016 |
| Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells M Abbaspour Babaei, B Kamalidehghan, M Saleem, HZ Huri, ... Drug design, development and therapy, 2443-2459, 2016 | 279 | 2016 |
| Drug related problems in type 2 diabetes patients with hypertension: a cross-sectional retrospective study H Zaman Huri, H Fun Wee BMC endocrine disorders 13, 1-12, 2013 | 173 | 2013 |
| Metabolomics–the complementary field in systems biology: a review on obesity and type 2 diabetes MHA Bakar, MR Sarmidi, KK Cheng, AA Khan, CL Suan, HZ Huri, ... Molecular BioSystems 11 (7), 1742-1774, 2015 | 115 | 2015 |
| Drug-related problems in type 2 diabetes mellitus patients with dyslipidemia H Zaman Huri, L Chai Ling BMC public health 13, 1-13, 2013 | 108 | 2013 |
| Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease SIQ Syed Ikmal, H Zaman Huri, SR Vethakkan, WA Wan Ahmad International journal of endocrinology 2013 (1), 698567, 2013 | 107 | 2013 |
| Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids M Hafizi Abu Bakar, C Kian Kai, WN Wan Hassan, MR Sarmidi, H Yaakob, ... Diabetes/metabolism research and reviews 31 (5), 453-475, 2015 | 74 | 2015 |
| Chemokine like receptor-1 (CMKLR-1) receptor: a potential therapeutic target in management of chemerin induced type 2 diabetes mellitus and cancer S Perumalsamy, N Ain Aqilah Mohd Zin, R Teguh Widodo, ... Current pharmaceutical design 23 (25), 3689-3698, 2017 | 51 | 2017 |
| Studies of the impact of occupational exposure of pharmaceutical workers on the development of antimicrobial drug resistance MMR Sarker, KN Islam, HZ Huri, M Rahman, H Imam, MB Hosen, ... Journal of occupational health 56 (4), 260-270, 2014 | 49 | 2014 |
| Genetic polymorphisms associated with overweight and obesity in uncontrolled Type 2 diabetes mellitus NB Kasim, HZ Huri, SR Vethakkan, L Ibrahim, BM Abdullah Biomarkers in medicine 10 (4), 403-415, 2016 | 48 | 2016 |
| Celastrol protects against antimycin A-induced insulin resistance in human skeletal muscle cells MH Abu Bakar, KK Cheng, MR Sarmidi, H Yaakob, H Zaman Huri Molecules 20 (5), 8242-8269, 2015 | 45 | 2015 |
| Drug-related problems in patients with rheumatoid arthritis SN Ma, H Zaman Huri, F Yahya Therapeutics and clinical risk management, 505-524, 2019 | 44 | 2019 |
| Clinical and genetic predictors of dipeptidyl peptidase-4 inhibitor treatment response in Type 2 diabetes mellitus JL Jamaluddin, HZ Huri, SR Vethakkan Pharmacogenomics 17 (8), 867-881, 2016 | 43 | 2016 |
| A survey amongst complementary alternative medicine (CAM) users with type 2 diabetes HZ Huri, GTP Lian, S Hussain, R Pendek, RT Widodo International Journal of Diabetes and Metabolism 17 (1), 9-15, 2009 | 41 | 2009 |
| Drug-related problems in patients with benign prostatic hyperplasia: a cross sectional retrospective study H Zaman Huri, C Hui Xin, CZ Sulaiman PloS one 9 (1), e86215, 2014 | 40 | 2014 |
| Altered circulating concentrations of active glucagon-like peptide (GLP-1) and dipeptidyl peptidase 4 (DPP4) in obese subjects and their association with insulin resistance RH Ahmed, HZ Huri, S Muniandy, Z Al-Hamodi, B Al-Absi, A Alsalahi, ... Clinical Biochemistry 50 (13-14), 746-749, 2017 | 39 | 2017 |
| Polyesters based on linoleic acid for biolubricant basestocks: Low-temperature, tribological and rheological properties BM Abdullah, SI Zubairi, HZ Huri, N Hairunisa, E Yousif, RC Basu PLoS One 11 (3), e0151603, 2016 | 39 | 2016 |
| Statin therapy prescribing for patients with type 2 diabetes mellitus: a review of current evidence and challenges MH Elnaem, MHN Mohamed, HZ Huri, SM Azarisman, RM Elkalmi Journal of Pharmacy and Bioallied Sciences 9 (2), 80-87, 2017 | 37 | 2017 |
| Association of psychological factors, patients’ knowledge, and management among patients with erectile dysfunction HZ Huri, ND Mat Sanusi, AHA Razack, R Mark Patient preference and adherence, 807-823, 2016 | 37 | 2016 |
| Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways M Hafizi Abu Bakar, MR Sarmidi, CK Kai, HZ Huri, H Yaakob International journal of molecular sciences 15 (12), 22227-22257, 2014 | 37 | 2014 |
